In A Nutshell Johns Hopkins researchers developed a blood test that catches 81% of stage IA lung cancers (the earliest, most ...

A newly identified metabolite in human feces improves immunotherapy and could radically change the treatment of lung cancer.

Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

A recent study reveals significant progress in biomarker testing for lung cancer in community settings, highlighting the need ...

Lung cancer varies widely from patient to patient, and that diversity makes it hard to find effective treatments. Researchers ...

Cancer immunotherapy has been a game-changer, but many tumors still find ways to slip past the immune system. New research ...

When the team knocked out the P2Y2 receptor in drug-resistant cancer cells, it led to an almost complete loss of the mutant EGFR protein.

A Chinese research team has developed the world's first blood-based diagnostic kit that can tell whether lung nodules are ...

Radon gas, an invisible health threat that can build up in your home, is putting more Canadians at risk of deadly lung cancer ...

Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene ...

Observational study finds more pathologic nodal upstaging with more nodes sampled ...